Research Nester published a report titled “Plasma Expressor Machine Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global plasma expressor machine market in terms of market segmentation by type, application, end-user, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global plasma expressor machine market is anticipated to attain a robust CAGR over the forecast period, i.e., 2022 – 2031. The market is divided on the basis of type into manual, and automatic, out of which, the automatic segment is estimated to gain larger share over the forecast period. This can be attributed to the easier operation of automatic plasma expressor machine for blood component separation. Moreover, there is a shortage for skilled professionals to handle the advanced medical equipment, which problem can be solved by using automatic machine. Furthermore, even though the automatic expressor machine is costlier initially, it eliminates the cost of a medical practitioner to operate it, therefore being cost effective in the longer run. Such factors are estimated to boost the segment growth.
The global plasma expressor machine market is estimated to grow on the back of high prevalence of blood cancer, and other infections. According to the data by World Health Organization (WHO), cancer is the second leading cause of death worldwide, accounting for 10 million deaths, in 2020. Plasma expressor machine is used for easy blood component separation, including red blood cells, white blood cells, platelets, and plasma. Moreover, rising adoption of advanced treatment methods to treat chronic diseases, is further anticipated to boost the market growth.
On the basis of geographical analysis, the global plasma expressor machine market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period, owing to the high prevalence of leukemia in the region. According to the data from National Cancer Institute, leukemia accounted for 3.2% of all new cancer cases, and 3.9% of all cancer deaths in the United States in 2020.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
High Prevalence of Blood Cancer to Boost the Market Growth
The growing cases of rare cancers, such as, leukemia, lymphoma, and multiple myeloma is anticipated to increase the demand for WBC, RBC and plasma transfusion for the treatment of these diseases. This is estimated to primarily boost the market growth. Along with this, the advancement in technology is further estimated to boost the market growth.
However, high maintenance cost and limited availability of advanced technology in low-income regions expected to operate as key restraint to the growth of global plasma expressor machine market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global plasma expressor machine market which includes company profiling of Escape Therapeutics, Inc., Lonza Group Ltd., Regen BioPharma, Inc., ThermoGenesis Holdings, Inc., CSG-BIO Company, Inc. (CellSave), CBR Systems, Inc., Pluristem Inc., Global Cord Blood Corporation, ViaCord, LLC, and Cynata Therapeutics Limited. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global plasma expressor machine market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Curious about this latest version of report? Obtain Report Details @ https://www.researchnester.com/reports/plasma-expressor-machine-market/3991
About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.